Raymond James Financial upgraded shares of LifePoint Health (NASDAQ:LPNT) from a market perform rating to an outperform rating in a report issued on Thursday, March 15th, MarketBeat.com reports. They currently have $57.00 price target on the stock.
Other analysts have also recently issued reports about the company. BidaskClub upgraded LifePoint Health from a hold rating to a buy rating in a research report on Thursday, March 1st. Morgan Stanley restated an equal weight rating and issued a $46.00 price objective (down from $50.00) on shares of LifePoint Health in a research report on Monday, February 26th. SunTrust Banks cut their price objective on LifePoint Health to $44.00 and set a hold rating for the company in a research report on Monday, February 26th. ValuEngine cut LifePoint Health from a buy rating to a hold rating in a research report on Sunday, December 31st. Finally, Zacks Investment Research upgraded LifePoint Health from a strong sell rating to a hold rating in a research report on Monday, January 22nd. One investment analyst has rated the stock with a sell rating, thirteen have issued a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $54.31.
Shares of NASDAQ:LPNT opened at $47.35 on Thursday. LifePoint Health has a 12-month low of $41.45 and a 12-month high of $67.95. The company has a market capitalization of $1,894.32, a price-to-earnings ratio of 13.04, a P/E/G ratio of 1.48 and a beta of 0.50. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.70 and a quick ratio of 1.49.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.04). The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The company’s revenue was down 7.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.07 earnings per share. sell-side analysts anticipate that LifePoint Health will post 4.23 EPS for the current year.
In related news, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now directly owns 252,673 shares in the company, valued at $12,259,693.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman William F. Carpenter III purchased 21,368 shares of the company’s stock in a transaction that occurred on Wednesday, February 28th. The shares were purchased at an average price of $46.80 per share, with a total value of $1,000,022.40. Following the completion of the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. 8.76% of the stock is currently owned by insiders.
A number of large investors have recently modified their holdings of the business. Xact Kapitalforvaltning AB purchased a new stake in LifePoint Health in the 4th quarter valued at $230,000. Letko Brosseau & Associates Inc. grew its holdings in LifePoint Health by 3.1% in the 4th quarter. Letko Brosseau & Associates Inc. now owns 1,429,654 shares of the company’s stock valued at $71,197,000 after buying an additional 43,615 shares in the last quarter. MetLife Investment Advisors LLC purchased a new stake in LifePoint Health in the 4th quarter valued at $1,242,000. Gotham Asset Management LLC grew its holdings in LifePoint Health by 138.3% in the 4th quarter. Gotham Asset Management LLC now owns 161,286 shares of the company’s stock valued at $8,032,000 after buying an additional 93,596 shares in the last quarter. Finally, Jane Street Group LLC purchased a new stake in LifePoint Health in the 4th quarter valued at $335,000.
TRADEMARK VIOLATION NOTICE: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/08/lifepoint-health-lpnt-upgraded-to-outperform-by-raymond-james-financial.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.